NDATOPICALSPONGE
Lifecycle
Pre-Launch
Data completeness
2/8 — Basic
CHLORHEXIDINE GLUCONATE (chlorhexidine gluconate) by Becton Dickinson is clinical pharmacology periogard® (chlorhexidine gluconate oral rinse usp, 0.
Drug data last refreshed 49m ago · AI intelligence enriched 6h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Chlorhexidine Gluconate is a topical antimicrobial oral rinse (0.12%) developed by Becton Dickinson that reduces bacterial plaque in the oral cavity through broad-spectrum antimicrobial activity. It achieves 54-97% reduction in oral bacteria counts and is retained in the oral cavity where it is slowly released into oral fluids. The product is indicated for oral hygiene and plaque reduction in patients requiring antimicrobial oral care.
$0.623MPart D
Pre-LaunchThis pre-launch topical product represents a market entry opportunity with 571 linked positions, suggesting significant infrastructure build-out across manufacturing, commercial, and engineering teams.
Mechanism of Action
CLINICAL PHARMACOLOGY PerioGard® (Chlorhexidine Gluconate Oral Rinse USP, 0.12%) provides antimicrobial activity during oral rinsing. The clinical significance of chlorhexidine gluconate oral rinse's antimicrobial activities is not clear. Microbiological sampling of plaque has shown a general…
Indications
Worked on CHLORHEXIDINE GLUCONATE at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.